Skip To Main Content
Lars Romer Krusell on Muck Rack

Lars Romer Krusell

Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Lars Romer

Contact Lars Romer, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Randomized Comparison of a Biodegradable Polymer Ultrathin Strut Sirolimus-Eluting Stent With a Biodegradable Polymer Biolimus-Eluting Stent in Patients Treated With Percutaneous Coronary Intervention

|
By Per Thayssen, Lars Romer Krusell, Anders Junker, Christian Juhl Terkelsen, Karsten Tange Veien, Knud Nørregaard Hansen, Henrik Hansen, Hans Erik Bøtker, Lisette Okkels Jensen, Michael Maeng, Jan Ravkilde, Bent Raungaard, Anton Boel Villadsen, Anne Kaltoft, Hans-Henrik Tilsted, Jens Aaroe, Steen Dalby Kristensen, Svend Eggert Jensen, Morten Madsen, Klára Berencsi, Jens Flensted Lassen
| circinterventions.ahajournals.org
Methods and Results—The Scandinavian Organization for Randomized Trials With Clinical Outcome (SORT OUT) VII trial—a large-scale registry-based randomized, multicenter, single-blind, 2-arm, noninferiority trial—compared 2 biodegradable polymer drug-eluting stents: the thin-strut cobalt–chromium sirolimus-eluting Orsiro stent and the stainless steel biolimus-eluting Nobori stent in an all-comer patient population.
Open in Who Shared Issue with article?

Fracturing the Ring of Small Mitroflow Bioprostheses by High-Pressure Balloon Predilatation in Transcatheter Aortic Valve-in-Valve Implantation

|
By Jens Erik Nielsen-Kudsk, Evald Høj Christiansen, Christian Juhl Terkelsen, Bjarne Linde Nørgaard, Kaare Troels Jensen, Lars Romer Krusell, Mariann Tang, Kim Terp, Kaj-Erik Klaaborg
| circinterventions.ahajournals.org
Early deterioration of Mitroflow aortic bioprostheses (Sorin Group Inc), particularly small sizes 19 and 21 mm, has been reported.1 Treatment of failing bioprostheses by transcatheter valve-in-valve (VIV) therapy has become an alternative to repeat surgery.2,3 However, VIV treatment is problematic with small surgical bioprostheses because of a further reduction in the effective valve orifice.
Open in Who Shared Issue with article?
See all 2 articles